XML 13 R4.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statement of Income (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Oct. 01, 2022
Sep. 30, 2023
Oct. 01, 2022
Income Statement [Abstract]        
Revenue (Notes 1 and 10) $ 244,182 $ 224,510 $ 718,993 $ 672,639
Costs and Operating Expenses:        
Cost of revenue 138,456 129,154 404,671 383,034
Selling, general, and administrative expenses 57,889 53,153 176,441 167,640
Research and development expenses 3,324 3,245 10,102 9,574
Gain on sale and other costs, net (Note 2) 969 72 1,043 (19,936)
Total Costs and Operating Expenses 200,638 185,624 592,257 540,312
Operating Income 43,544 38,886 126,736 132,327
Interest Income 438 271 1,053 650
Interest Expense (2,107) (1,721) (6,722) (4,321)
Other Expense, Net (20) (19) (62) (60)
Income Before Provision for Income Taxes 41,855 37,417 121,005 128,596
Provision for Income Taxes (Note 4) 10,816 9,746 31,761 33,075
Net Income 31,039 27,671 89,244 95,521
Net Income Attributable to Noncontrolling Interest (175) (184) (571) (672)
Net Income Attributable to Kadant $ 30,864 $ 27,487 $ 88,673 $ 94,849
Earnings per Share Attributable to Kadant (Note 3)        
Basic (in dollars per share) $ 2.64 $ 2.36 $ 7.58 $ 8.14
Diluted (in dollars per share) $ 2.63 $ 2.35 $ 7.57 $ 8.12
Weighted Average Shares (Note 3)        
Basic (in shares) 11,706 11,662 11,697 11,651
Diluted (in shares) 11,740 11,700 11,719 11,681